Qube Research & Technologies (QRT)
EVMN icon

Qube Research & Technologies (QRT)’s Evommune Inc EVMN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Buy
+30,115
New +$700K ﹤0.01% 2722
2026
Q1 		– Sell
-24,057
Closed -$412K – 4266
2025
Q4 		$412K Buy
+24,057
New +$452K ﹤0.01% 2861

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVMN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Evommune Inc (EVMN) in Q2 2026: 30,115 shares worth $400K. The stake represents ﹤0.01% of the portfolio and ranks #2722 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in EVMN as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in EVMN in Q4 2025 and has held it in 2 quarters since. The position peaked at $412K in Q4 2025. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Qube Research & Technologies (QRT) held 30,115 shares of Evommune Inc worth $400K as of Q2 2026.
  • Evommune Inc was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • Evommune Inc made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2722 holding.
  • Qube Research & Technologies (QRT) first reported a position in Evommune Inc in Q4 2025 and has held it in 2 quarters since.
  • Qube Research & Technologies (QRT)'s Evommune Inc position peaked at $412K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.